8.152
1.19%
0.092
전일 마감가:
$8.06
열려 있는:
$8
하루 거래량:
2.08M
Relative Volume:
0.33
시가총액:
$1.31B
수익:
$793.74M
순이익/손실:
$-398.71M
주가수익비율:
-1.1229
EPS:
-7.26
순현금흐름:
$-514.43M
1주 성능:
+12.97%
1개월 성능:
-19.57%
6개월 성능:
-45.30%
1년 성능:
+52.45%
노바백스 Stock (NVAX) Company Profile
명칭
Novavax Inc
전화
240-268-2000
주소
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
NVAX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
NVAX | 8.145 | 1.31B | 793.74M | -398.71M | -514.43M | -7.26 |
VRTX | 449.14 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 748.83 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 587.39 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 248.01 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.00 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
노바백스 Stock (NVAX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-08-09 | 업그레이드 | B. Riley Securities | Neutral → Buy |
2023-04-20 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
2023-03-01 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
2023-01-09 | 재확인 | B. Riley Securities | Buy |
2022-12-30 | 재확인 | H.C. Wainwright | Buy |
2022-12-02 | 개시 | Jefferies | Hold |
2022-09-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2022-05-20 | 개시 | BofA Securities | Underperform |
2022-02-23 | 재확인 | B. Riley Securities | Buy |
2022-02-22 | 재개 | Jefferies | Buy |
2022-01-21 | 개시 | Cowen | Outperform |
2021-05-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2020-12-14 | 개시 | Jefferies | Buy |
2020-08-06 | 재확인 | H.C. Wainwright | Buy |
2020-08-05 | 업그레이드 | JP Morgan | Neutral → Overweight |
2020-08-05 | 다운그레이드 | Ladenburg Thalmann | Neutral → Sell |
2020-07-16 | 재확인 | H.C. Wainwright | Buy |
2020-07-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
2020-06-29 | 재확인 | B. Riley FBR | Buy |
2020-06-29 | 재확인 | H.C. Wainwright | Buy |
2020-06-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
2020-05-28 | 재확인 | B. Riley FBR | Buy |
2020-05-12 | 재확인 | H.C. Wainwright | Buy |
2020-04-30 | 재확인 | H.C. Wainwright | Buy |
2019-11-27 | 재개 | B. Riley FBR | Buy |
2019-08-14 | 재확인 | H.C. Wainwright | Buy |
2019-02-28 | 다운그레이드 | Piper Jaffray | Overweight → Underweight |
2018-12-18 | 개시 | Ladenburg Thalmann | Buy |
2018-12-11 | 개시 | Oppenheimer | Outperform |
2018-11-26 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
2018-09-21 | 업그레이드 | JP Morgan | Underweight → Overweight |
2018-03-29 | 업그레이드 | Seaport Global Securities | Neutral → Buy |
모두보기
노바백스 주식(NVAX)의 최신 뉴스
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Menopause Treatment Market Opportunities, Challenges, - openPR
What is B. Riley's Estimate for Novavax FY2024 Earnings? - MarketBeat
Novavax to Present at Jefferies London Conference - TipRanks
Preventive Vaccines Market May Set New Growth Story | Takeda - openPR
Health Care Flat After Last Week's SelloffHealth Care Roundup - Marketscreener.com
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance
How To Trade (NVAX) - Stock Traders Daily
FY2024 Earnings Forecast for Novavax Issued By HC Wainwright - MarketBeat
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Big Pharma Stocks Drop After RFK Jr. Announced as Health Secretary - Newsweek
Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? - Yahoo! Voices
UK regulator approves adapted Novavax jab - The Pharma Letter
Health stocks slide as Trump picks vaccine skeptic Kennedy - Los Angeles Times
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Vaccine maker stocks fall after conspiracy theory-spreading RFK Jr. tapped to lead health department - New York Post
Shot Down: Vaccine stocks tumble with RFK Jr. as Health SecretaryFinbold - Finbold - Finance in Bold
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharma - The New York Times
Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target - Simply Wall St
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Malaysian Reserve
Vaccine Stocks Fall After Trump Selects RFK Jr. to Lead HHS - Yahoo Finance
Novavax Grants Stock Options, RSUs to New R&D Chief in Executive Compensation Deal | NVAX Stock News - StockTitan
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's
Vaccine Maker Stocks Fall After Trump Taps RFK Jr. to Head HHS - MSN
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary - CNN
Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Big Pharma stocks tumble as Trump nominates RFK Jr. to lead HHS - The National Desk
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower - Benzinga
Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut - MSN
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data - Yahoo Finance
Novavax to Participate in Jefferies London Healthcare Conference - StreetInsider.com
Novavax Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Novavax (NVAX) Stock Experiences Significant Drop Amid Industry Volatility - GuruFocus.com
Protein-based Vaccine Sales Strategy Advances - Precision Vaccinations
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript - Insider Monkey
Stock Market Increases While Tesla And Novavax Take A Hit - Finimize
Novavax CEO to Present at Jefferies Healthcare Conference in London | NVAX Stock News - StockTitan
Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway (NASDAQ:NVAX) - Seeking Alpha
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic P - GuruFocus.com
Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ... - Yahoo Finance
Novavax Advances Vaccine Strategy Amid Financial Shifts - TipRanks
Earnings call: Novavax outlines strategic growth and partnership with Sanofi - Investing.com
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
노바백스 (NVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
노바백스 주식 (NVAX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Trizzino John | EVP, CCO and CBO |
Aug 19 '24 |
Option Exercise |
0.00 |
655 |
0 |
28,627 |
Kelly James Patrick | EVP, CFO and Treasurer |
Aug 16 '24 |
Option Exercise |
12.96 |
2,367 |
30,676 |
15,652 |
YOUNG JAMES F | Director |
Jun 21 '24 |
Sale |
14.09 |
7,500 |
105,675 |
61,760 |
YOUNG JAMES F | Director |
Jun 18 '24 |
Sale |
13.72 |
7,500 |
102,881 |
69,260 |
Dubovsky Filip | President, R&D |
Jun 17 '24 |
Option Exercise |
6.18 |
13,904 |
85,911 |
80,517 |
Dubovsky Filip | President, R&D |
Jun 17 '24 |
Sale |
14.47 |
13,904 |
201,164 |
66,613 |
MCGLYNN MARGARET G | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
10,470 |
Alton Gregg H | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
10,470 |
DOUGLAS RICHARD | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
43,920 |
King Rachel K. | Director |
Jun 12 '24 |
Option Exercise |
0.00 |
6,670 |
0 |
18,920 |
자본화:
|
볼륨(24시간):